These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 28129736)
21. Diagnostic and prognostic value of a careful symptom evaluation and high sensitive troponin in patients with suspected stable angina pectoris without prior cardiovascular disease. Madsen DM; Diederichsen ACP; Hosbond SE; Gerke O; Mickley H Atherosclerosis; 2017 Mar; 258():131-137. PubMed ID: 28031149 [TBL] [Abstract][Full Text] [Related]
22. Prognostic value of remnant-like lipoprotein particle levels in patients with coronary artery disease and type II diabetes mellitus. Fukushima H; Sugiyama S; Honda O; Koide S; Nakamura S; Sakamoto T; Yoshimura M; Ogawa H; Fujioka D; Kugiyama K J Am Coll Cardiol; 2004 Jun; 43(12):2219-24. PubMed ID: 15193683 [TBL] [Abstract][Full Text] [Related]
24. Impact of routine coronary catheterization in low extremity artery disease undergoing percutaneous transluminal angioplasty: study protocol for a multi-center randomized controlled trial. Chen IC; Lee CH; Chao TH; Tseng WK; Lin TH; Chung WJ; Li JK; Huang HL; Liu PY; Chao TK; Chu CY; Lin CC; Hsu PC; Lee WH; Lee PT; Li YH; Tseng SY; Tsai LM; Hwang JJ Trials; 2016 Feb; 17(1):112. PubMed ID: 26927298 [TBL] [Abstract][Full Text] [Related]
25. Lack of association between lipoprotein(a) genetic variants and subsequent cardiovascular events in Chinese Han patients with coronary artery disease after percutaneous coronary intervention. Li ZG; Li G; Zhou YL; Chen ZJ; Yang JQ; Zhang Y; Sun S; Zhong SL Lipids Health Dis; 2013 Aug; 12():127. PubMed ID: 23978127 [TBL] [Abstract][Full Text] [Related]
26. Plasma adiponectin levels in relation to prognosis in patients with angiographic coronary artery disease. Li Q; Lu Y; Sun L; Yan J; Yan X; Fang L; Li M; Fan Z Metabolism; 2012 Dec; 61(12):1803-8. PubMed ID: 22789446 [TBL] [Abstract][Full Text] [Related]
27. Achievement of optimal medical therapy goals for U.S. adults with coronary artery disease: results from the REGARDS Study (REasons for Geographic And Racial Differences in Stroke). Brown TM; Voeks JH; Bittner V; Brenner DA; Cushman M; Goff DC; Glasser S; Muntner P; Tabereaux PB; Safford MM J Am Coll Cardiol; 2014 Apr; 63(16):1626-33. PubMed ID: 24534599 [TBL] [Abstract][Full Text] [Related]
28. Incremental prognostic value of computed tomography in stroke: rationale and design of the IMPACTS study. Lee JW; Hur J; Choi SI; Chun EJ; Kang JW; Jin GY; Kim EY; Yong HS; Kang EJ; Han K; Lee HS; Choi BW Int J Cardiovasc Imaging; 2016 Jun; 32 Suppl 1():83-9. PubMed ID: 26910046 [TBL] [Abstract][Full Text] [Related]
31. Type D Personality, Social Support, and Depression Among Ethnic Chinese Coronary Artery Disease Patients Undergoing a Percutaneous Coronary Intervention: An Exploratory Study. Su SF; He CP Psychol Rep; 2019 Jun; 122(3):988-1006. PubMed ID: 29848215 [TBL] [Abstract][Full Text] [Related]
32. Low high-density lipoprotein cholesterol is a residual risk factor associated with long-term clinical outcomes in diabetic patients with stable coronary artery disease who achieve optimal control of low-density lipoprotein cholesterol. Ogita M; Miyauchi K; Miyazaki T; Naito R; Konishi H; Tsuboi S; Dohi T; Kasai T; Yokoyama T; Okazaki S; Kurata T; Daida H Heart Vessels; 2014 Jan; 29(1):35-41. PubMed ID: 23516028 [TBL] [Abstract][Full Text] [Related]
33. Impact of acarbose on carotid intima-media thickness in patients with newly diagnosed impaired glucose tolerance or mild type 2 diabetes mellitus: A one-year, prospective, randomized, open-label, parallel-group study in Japanese adults with established coronary artery disease. Koyasu M; Ishii H; Watarai M; Takemoto K; Inden Y; Takeshita K; Amano T; Yoshikawa D; Matsubara T; Murohara T Clin Ther; 2010 Aug; 32(9):1610-7. PubMed ID: 20974318 [TBL] [Abstract][Full Text] [Related]
34. B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial. Redfors B; Chen S; Crowley A; Ben-Yehuda O; Gersh BJ; Lembo NJ; Brown WM; Banning AP; Taggart DP; Serruys PW; Kappetein AP; Sabik JF; Stone GW Circulation; 2018 Jul; 138(5):469-478. PubMed ID: 29666071 [TBL] [Abstract][Full Text] [Related]
35. Coronary severity score and C-reactive protein predict major adverse cardiovascular events in patients with stable coronary artery disease (from the Taichung CAD study). Pan HC; Sheu WH; Lee WJ; Lee WL; Liao YC; Wang KY; Lee IT; Wang JS; Liang KW Clin Chim Acta; 2015 May; 445():93-100. PubMed ID: 25818243 [TBL] [Abstract][Full Text] [Related]
36. Characteristics and the average 30-day and 6-month clinical outcomes of patients hospitalised with coronary artery disease in a poor South-East Asian setting: the first cohort from Makassar Cardiac Center, Indonesia. Qanitha A; Uiterwaal CSPM; Henriques JPS; Alkatiri AH; Mappangara I; Mappahya AA; Patellongi I; de Mol BAJM BMJ Open; 2018 Jun; 8(6):e021996. PubMed ID: 29950477 [TBL] [Abstract][Full Text] [Related]
37. High-density lipoprotein cholesterol levels are associated with coronary severity but not with outcomes in new-onset patients with stable coronary artery disease. Liu HH; Guo YL; Wu NQ; Zhu CG; Gao Y; Qing P; Li S; Zhao X; Zhang Y; Sun D; Liu G; Dong Q; Li JJ Atherosclerosis; 2017 Aug; 263():104-111. PubMed ID: 28623739 [TBL] [Abstract][Full Text] [Related]
38. Hypotheses, rationale, design, and methods for prognostic evaluation of cardiac biomarker elevation after percutaneous and surgical revascularization in the absence of manifest myocardial infarction. A comparative analysis of biomarkers and cardiac magnetic resonance. The MASS-V Trial. Hueb W; Gersh BJ; Rezende PC; Garzillo CL; Lima EG; Vieira RD; Garcia RM; Favarato D; Segre CA; Pereira AC; Soares PR; Ribeiro E; Lemos P; Perin MA; Strunz CC; Dallan LA; Jatene FB; Stolf NA; Hueb AC; Dias R; Gaiotto FA; da Costa LM; Oikawa FT; de Melo RM; Serrano CV; de Ávila LF; Villa AV; Filho JR; Nomura C; Ramires JA; Kalil Filho R; BMC Cardiovasc Disord; 2012 Aug; 12():65. PubMed ID: 22898311 [TBL] [Abstract][Full Text] [Related]
39. Rationale and Design of Randomized Evaluation of Aggressive or Moderate Lipid Lowering Therapy with Pitavastatin in Coronary Artery Disease (REAL-CAD) Trial. Miyauchi K; Kimura T; Shimokawa H; Daida H; Iimuro S; Iwata H; Ozaki Y; Sakuma I; Nakagawa Y; Hibi K; Hiro T; Fukumoto Y; Hokimoto S; Ohashi Y; Ohtsu H; Saito Y; Matsuzaki M; Nagai R; Int Heart J; 2018 Mar; 59(2):315-320. PubMed ID: 29503404 [TBL] [Abstract][Full Text] [Related]
40. Impact of treatment strategies on outcomes in patients with stable coronary artery disease and type 2 diabetes mellitus according to presenting angina severity: A pooled analysis of three federally-funded randomized trials. Mancini GBJ; Boden WE; Brooks MM; Vlachos H; Chaitman BR; Frye R; Bittner V; Hartigan PM; Dagenais GR Atherosclerosis; 2018 Oct; 277():186-194. PubMed ID: 29861270 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]